Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis

11 Jan 2021

Abstract excerpt

Development of novel anti-tuberculosis combination regimens that increase efficacy and reduce treatment timelines will improve patient compliance, limit side-effects, reduce costs, and enhance cure rates. Such advancements would significantly improve the global TB burden and reduce drug resistance acquisition. Bioenergetics has received considerable attention in recent years as a fertile area for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Cancer therapeutics and mechanisms
Share to Tuberculosis Research and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33505923
DOI: 10.3389/fcimb.2020.611683

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosisPMID 33505923Read ↗

Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosisSemantic proximity Read ↗

Energy Metabolism and Drug Efflux in Mycobacterium tuberculosisSemantic proximity Read ↗

Turning the respiratory flexibility of Mycobacterium tuberculosis against itself.Semantic proximity Read ↗

Compromised Metabolic Reprogramming Is an Early Indicator of CD8+ T Cell Dysfunction during Chronic Mycobacterium tuberculosis InfectionSemantic proximity Read ↗

Mycobacterial Control of Host Mitochondria: Bioenergetic and Metabolic Changes Shaping Cell Fate and Infection OutcomeSemantic proximity Read ↗

Mechanism-based inactivator of isocitrate lyases 1 and 2 from Mycobacterium tuberculosisSemantic proximity Read ↗

Uncovering the Roles of <i>Mycobacterium tuberculosis melH</i> in Redox and Bioenergetic Homeostasis: Implications for Antitubercular TherapySemantic proximity Read ↗

Impaired succinate oxidation prevents growth and influences drug susceptibility in <i>Mycobacterium tuberculosis</i>Semantic proximity Read ↗

Molecular, biochemical and pharmacological characterisation of Mycobacterium tuberculosis cytochrome bd-I oxidase : a putative therapeutic targetSemantic proximity Read ↗

Targeting DNA Replication and Repair for the Development of Novel Therapeutics against TuberculosisSemantic proximity Read ↗

Antibiotic efficacy is linked to bacterial cellular respiration.Semantic proximity Read ↗

Multiplexed transcriptional repression identifies a network of bactericidal interactions between mycobacterial respiratory complexesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.